BSW Wealth Partners Buys 210 Shares of Elevance Health, Inc. (NYSE:ELV)

BSW Wealth Partners boosted its stake in Elevance Health, Inc. (NYSE:ELV) by 42.1% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 709 shares of the company’s stock after purchasing an additional 210 shares during the period. BSW Wealth Partners’ holdings in Elevance Health were worth $262,000 at the end of the most recent quarter.

A number of other hedge funds have also recently added to or reduced their stakes in ELV. Raelipskie Partnership bought a new position in shares of Elevance Health in the 3rd quarter valued at $26,000. PSI Advisors LLC acquired a new position in Elevance Health in the 3rd quarter worth about $27,000. Eastern Bank bought a new position in Elevance Health in the third quarter valued at about $31,000. Dunhill Financial LLC boosted its stake in shares of Elevance Health by 57.8% during the third quarter. Dunhill Financial LLC now owns 71 shares of the company’s stock valued at $37,000 after purchasing an additional 26 shares in the last quarter. Finally, Peterson Financial Group Inc. bought a new stake in shares of Elevance Health during the third quarter worth about $44,000. Institutional investors and hedge funds own 89.24% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts recently commented on the stock. Morgan Stanley cut their target price on shares of Elevance Health from $643.00 to $551.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 23rd. StockNews.com lowered shares of Elevance Health from a “buy” rating to a “hold” rating in a report on Monday. TD Cowen decreased their price objective on Elevance Health from $589.00 to $484.00 and set a “buy” rating for the company in a report on Monday, October 21st. Wells Fargo & Company cut their target price on Elevance Health from $483.00 to $478.00 and set an “overweight” rating on the stock in a report on Tuesday. Finally, Truist Financial decreased their price target on Elevance Health from $520.00 to $480.00 and set a “buy” rating for the company in a research note on Monday, January 6th. Four equities research analysts have rated the stock with a hold rating, twelve have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average target price of $517.03.

Elevance Health Trading Down 1.2 %

ELV opened at $400.62 on Thursday. The company has a fifty day moving average price of $386.65 and a two-hundred day moving average price of $459.57. Elevance Health, Inc. has a 1-year low of $362.21 and a 1-year high of $567.26. The company has a market cap of $92.91 billion, a P/E ratio of 14.61, a price-to-earnings-growth ratio of 1.11 and a beta of 0.84. The company has a current ratio of 1.50, a quick ratio of 1.50 and a debt-to-equity ratio of 0.56.

Elevance Health (NYSE:ELV) last issued its earnings results on Thursday, January 23rd. The company reported $3.84 EPS for the quarter, beating analysts’ consensus estimates of $3.80 by $0.04. Elevance Health had a return on equity of 19.56% and a net margin of 3.68%. Analysts predict that Elevance Health, Inc. will post 32.95 EPS for the current fiscal year.

Elevance Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, March 25th. Investors of record on Monday, March 10th will be issued a $1.71 dividend. This is a boost from Elevance Health’s previous quarterly dividend of $1.63. This represents a $6.84 dividend on an annualized basis and a dividend yield of 1.71%. The ex-dividend date of this dividend is Monday, March 10th. Elevance Health’s dividend payout ratio (DPR) is currently 26.71%.

About Elevance Health

Elevance Health, Inc, together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits.